Healio Rheumatology Current Issue
The following articles appeared in the print edition of Healio Rheumatology.
Table of Contents
- Therapeutic Drug Monitoring Not Ready for Prime Time in Rheumatology
-
- FDA Approves Avsola, Fourth Remicade Biosimilar
- European Commission Approves Subcutaneous Infliximab Biosimilar for RA
- What’s on Your Shelf? Recommended Reading in the New Year Leonard H. Calabrese, DO
- ACR, EULAR Release First Classification Criteria for IgG4
- ACR Permits Use of Multibiomarker Disease Activity Score in Updated RA Recommendations
- EULAR: Immunosuppressants Only to Spare Steroid Use in Sjögren’s Syndrome
- Ace the Case: A 63-Year-Old Man With a 1-Week History of Headache and Neck Pain
- ACA’s Individual Mandate Ruled Unconstitutional, Case Sent Back to District Court
-
- Job Dissatisfaction Greater Predictor of Sick Leave Than Fibromyalgia Disease Factors
- Price Increases Largely to Blame for $3 Billion Spending Hike on Biologic DMARDs
- Scarcity of Lupus Assays in Developing Countries Limit Utility of International Criteria, Trials
- Coalition of State Rheumatology Organizations Takes Action for Advocacy
- Apremilast Reduces Number of Behçet’s-related Oral Ulcers
- RA Increases Risk for CV Disease, Sleep Apnea, Venous Thromboembolism
- Transcutaneous Electrical Nerve Stimulation Improves Fibromyalgia Pain
- Celebrating the Life of Calvin R. Brown, Jr., MD, Rheumatologist and Teacher
-